We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+11.36%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$67.2B
AUM Growth
+$10.7B
(+19%)
Cap. Flow
+$4.46B
Cap. Flow
% of AUM
6.63%
Top 10 Holdings %
Top 10 Hldgs %
6.15%
Holding
4,027
New
877
Increased
1,461
Reduced
1,084
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$474M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$357M |
| 3 |
Accenture
ACN
|
+$246M |
| 4 |
Advanced Micro Devices
AMD
|
+$235M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$375M |
| 3 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$348M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$292M |
| 5 |
Snowflake
SNOW
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.18% |
| 2 | Financials | 15.54% |
| 3 | Industrials | 10.5% |
| 4 | Healthcare | 9.8% |
| 5 | Consumer Discretionary | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
2026
DELISTED
Olympic Steel
ZEUS
| $2.08M | ﹤0.01% |
68,147
+11,490
| +20% | +$377K |
|
2027
Ameris Bancorp
ABCB
$5.74B
| $2.07M | ﹤0.01% |
28,257
+12,838
| +83% | +$904K |
|
2028
Outset Medical
OM
$80.8M
| $2.07M | ﹤0.01% |
146,598
+72,504
| +98% | +$1.13M |
|
2029
Crinetics Pharmaceuticals
CRNX
$9B
| $2.07M | ﹤0.01% |
49,699
-3,080
| -6% | -$98.5K |
|
2030
Republic Bancorp
RBCAA
$1.85B
| $2.07M | ﹤0.01% |
28,631
+10,916
| +62% | +$806K |
|
2031
Zentalis Pharmaceuticals
ZNTL
$367M
| $2.06M | ﹤0.01% |
1,363,347
+270,294
| +25% | +$405K |
|
2032
WisdomTree Japan Hedged Equity Fund
DXJ
$7.27B
| $2.05M | ﹤0.01% |
16,000
+9,300
| +139% | +$1.14M |
|
2033
iShares S&P Small-Cap 600 Value ETF
IJS
$8.29B
| $2.05M | ﹤0.01% |
+18,500
| New | +$1.96M |
|
|
IRBT
2034
DELISTED
iRobot
IRBT
| $2.04M | ﹤0.01% |
568,257
+229,151
| +68% | +$886K |
|
2035
Daktronics
DAKT
$923M
| $2.04M | ﹤0.01% |
97,321
-58,584
| -38% | -$1.05M |
|
2036
Travelers Companies
TRV
$77.1B
| $2.04M | ﹤0.01% |
7,290
-25,789
| -78% | -$6.91M |
|
2037
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
| $2.03M | ﹤0.01% |
+15,600
| New | +$1.96M |
|
2038
Civista Bancshares
CIVB
$569M
| $2.03M | ﹤0.01% |
100,015
+83,438
| +503% | +$1.75M |
|
|
BTM
2039
DELISTED
Bitcoin Depot
BTM
| $2.03M | ﹤0.01% |
86,341
+13,929
| +19% | +$436K |
|
2040
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.96B
| $2.03M | ﹤0.01% |
11,300
-400
| -3% | -$68.1K |
|
2041
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$255M
| $2.02M | ﹤0.01% |
+69,200
| New | +$2.1M |
|
2042
Heritage Insurance Holdings
HRTG
$1.02B
| $2.02M | ﹤0.01% |
80,269
-15,263
| -16% | -$347K |
|
2043
CALL
Albemarle
ALB
$15.7B
| $2.02M | ﹤0.01% |
24,900
| – | – |
|
2044
Ring Energy
REI
$375M
| $2.02M | ﹤0.01% |
1,849,178
+1,431,162
| +342% | +$1.3M |
|
|
TIXT
2045
DELISTED
TELUS International
TIXT
| $2.01M | ﹤0.01% |
449,594
-203,741
| -31% | -$826K |
|
|
MIAX
2046
Miami International Holdings
MIAX
$4.4B
| $2.01M | ﹤0.01% |
+50,011
| New | +$1.83M |
|
2047
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.01M | ﹤0.01% |
+4,000
| New | +$1.94M |
|
2048
Victory Capital Holdings
VCTR
$7.09B
| $2M | ﹤0.01% |
+30,944
| New | +$2.12M |
|
2049
Invesco S&P MidCap Low Volatility ETF
XMLV
$743M
| $2M | ﹤0.01% |
31,500
-1,500
| -5% | -$94.1K |
|
2050
Columbia Banking Systems
COLB
$8.64B
| $2M | ﹤0.01% |
+77,722
| New | +$1.97M |
|
Similar funds
John Overdeck's Q3 2025 Portfolio in Review
As of Q3 2025, John Overdeck held 4,027 positions worth $67.2B, up 19% from $56.5B the previous quarter. Its ten largest holdings account for 6.2% of the portfolio.
John Overdeck deployed $4.46B of net new capital in Q3 2025, opening 877 new positions and adding to 1,461 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 379,096 shares worth $191M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $381M trimmed.
- John Overdeck's largest Q3 2025 buy was Berkshire Hathaway Class B: 379,096 shares worth $191M.
- John Overdeck added most to State Street Financial Select Sector SPDR ETF in Q3 2025, an estimated $474M increase.
- John Overdeck's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $381M.
- John Overdeck fully exited NextEra Energy, Inc. 6.926% Corporate Units in Q3 2025, selling an estimated $115M.
- John Overdeck's ten largest holdings make up 6.2% of its $67.2B portfolio in Q3 2025.
- John Overdeck opened 877 new positions and closed 399 in Q3 2025.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $67.2B.
Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.